Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.
View Top Employees from Biotechnology Innovation OrganizationWebsite | http://www.bio.org |
Funding | $24 million |
Employees | 3 (3 on RocketReach) |
Address | 1767 King St, Alexandria, Virginia 22314, US |
Phone | (202) 962-9200 |
Industry | Membership Organizations, Organizations |
SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Biotechnology Innovation Organization employee's phone or email?
3 people are employed at Biotechnology Innovation Organization.
Biotechnology Innovation Organization is based in Alexandria, Virginia.
The NAICS codes for Biotechnology Innovation Organization are [3254, 325, 32541, 32].
The SIC codes for Biotechnology Innovation Organization are [283, 2834, 28].